Ladenburg Thalmann analyst Aydin Huseynov downgrades Calithera Biosciences (NASDAQ:CALA) from Buy to Neutral.
Nasdaq Sends Non-Compliance Notice To Atlantic Coastal Acquisition On April 3 After It Fails To Adhere To Independent Director Norms
On March 21, 2023, as previously reported, Daniel M. Tapiero resigned from the Board of Directors (the “Board”), and all committees thereof, of Atlantic Coastal Acquisition Corp. (the “Company”).
